Fig. 3From: Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinomaKaplan-Meier curves for disease-free survival and overall survival according to ROS1 expression. ROS-expressing tumors were associated with better disease-free survival (30.1 months for ROS1 expression (+) tumors vs. 9.0 months for ROS1 (−) tumors, p = 0.006). Also, patients with ROS1 (+) tumors had better overall survival, not reaching statistical significance (p = 0.071)Back to article page